evaluation of these targets , both in vitro as inhibitors of platelet or cardiac type iv pde or in vivo as inotropic agents in the pentobarbital-anesthetized dog model of congestive heart failure , showed that these structure possessed negligibly enhanced activities over the parent heterocyclic system , and remained significantly inferior to 1 in all respects .
C0018787
cardiac
C0018802
congestive heart failure